Skip to main content
main-content
Erschienen in: Gastro-News 2/2022

20.04.2022 | Obstipation | Zertifizierte Fortbildung

Funktionelle Magen-Darm-Erkrankungen

Therapie-Update Reizdarmsyndrom

verfasst von: Prof. Dr. med. Martin Storr

Erschienen in: Gastro-News | Ausgabe 2/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Auszug

Das Reizdarmsyndrom ist eine funktionelle Magen-Darm-Erkrankung mit sehr hoher Prävalenz [ 1]. Die vor kurzem erschienene aktualisierte S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten sowie der Deutschen Gesellschaft für Neurogastroenterologie und Motilität ist Anlass, sich erneut mit den therapeutischen Optionen zu beschäftigen [ 2].
Literatur
1.
Zurück zum Zitat Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325-32 Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325-32
2.
Zurück zum Zitat Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie des Reizdarmsyndroms der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) Layer P et al., 2021 ZfG, in press Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie des Reizdarmsyndroms der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) Layer P et al., 2021 ZfG, in press
3.
Zurück zum Zitat Hotz J, Enck P, Goebell H, Heymann-Monnikes I, Holtmann G, Layer P. [Consensus report: irritable bowel syndrome--definition, differential diagnosis, pathophysiology and therapeutic possibilities. Consensus of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol. 1999;37(8):685-700 Hotz J, Enck P, Goebell H, Heymann-Monnikes I, Holtmann G, Layer P. [Consensus report: irritable bowel syndrome--definition, differential diagnosis, pathophysiology and therapeutic possibilities. Consensus of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol. 1999;37(8):685-700
4.
Zurück zum Zitat Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med. 1995;122(2):107-12 Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med. 1995;122(2):107-12
5.
Zurück zum Zitat Sullivan SN. Management of the irritable bowel syndrome: a personal view. J Clin Gastroenterol. 1983;5(6):499-502 Sullivan SN. Management of the irritable bowel syndrome: a personal view. J Clin Gastroenterol. 1983;5(6):499-502
6.
Zurück zum Zitat Monsbakken KW, Vandvik PO, Farup PG. The value of a general therapeutic approach in subjects with irritable bowel syndrome. Aliment Pharmacol Ther. 2005;21(1):21-7 Monsbakken KW, Vandvik PO, Farup PG. The value of a general therapeutic approach in subjects with irritable bowel syndrome. Aliment Pharmacol Ther. 2005;21(1):21-7
7.
Zurück zum Zitat Saito YA, Prather CM, Van Dyke CT, Fett S, Zinsmeister AR, Locke GR, 3 rd. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004;2(7):576-84 Saito YA, Prather CM, Van Dyke CT, Fett S, Zinsmeister AR, Locke GR, 3 rd. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004;2(7):576-84
8.
Zurück zum Zitat Kuttner L, Chambers CT, Hardial J, Israel DM, Jacobson K, Evans K. A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag. 2006;11(4):217-23 Kuttner L, Chambers CT, Hardial J, Israel DM, Jacobson K, Evans K. A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag. 2006;11(4):217-23
9.
Zurück zum Zitat Bohn L, Storsrud S, Tornblom H, Bengtsson U, Simren M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108(5):634-41 Bohn L, Storsrud S, Tornblom H, Bengtsson U, Simren M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108(5):634-41
10.
Zurück zum Zitat O'Keeffe M, Jansen C, Martin L, Williams M, Seamark L, Staudacher HM et al. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterol Motil. 2018 Jan;30(1). doi: 10.1111/nmo.13154. Epub 2017 Jul 14. O'Keeffe M, Jansen C, Martin L, Williams M, Seamark L, Staudacher HM et al. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterol Motil. 2018 Jan;30(1). doi: 10.1111/nmo.13154. Epub 2017 Jul 14.
11.
Zurück zum Zitat Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41(12):1256-70 Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41(12):1256-70
12.
Zurück zum Zitat Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67-75.e5 Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67-75.e5
13.
Zurück zum Zitat Schaefert R, Klose P, Moser G, Hauser W. Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: systematic review and meta-analysis. Psychosom Med. 2014;76(5):389-98 Schaefert R, Klose P, Moser G, Hauser W. Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: systematic review and meta-analysis. Psychosom Med. 2014;76(5):389-98
14.
Zurück zum Zitat Ljotsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Ruck C et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome - a randomized controlled trial. Behav Res Ther. 2010;48(6):531-9 Ljotsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Ruck C et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome - a randomized controlled trial. Behav Res Ther. 2010;48(6):531-9
15.
Zurück zum Zitat Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med. 2000;62(3):309-17 Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med. 2000;62(3):309-17
16.
Zurück zum Zitat Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2012(5):Cd005111 Manheimer E, Cheng K, Wieland LS, Min LS, Shen X, Berman BM, et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2012(5):Cd005111
17.
Zurück zum Zitat Park JW, Lee BH, Lee H. Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis. BMC Complement Altern Me 2013;13:247 Park JW, Lee BH, Lee H. Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis. BMC Complement Altern Me 2013;13:247
18.
Zurück zum Zitat Liu JP, Yang M, Liu YX, Wei M, Grimsgaard S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006(1):CD004116 Liu JP, Yang M, Liu YX, Wei M, Grimsgaard S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006(1):CD004116
19.
Zurück zum Zitat Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313 Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313
20.
Zurück zum Zitat Parker EA, Roy T, D'Adamo CR, Wieland LS. Probiotics and gastrointestinal conditions: an overview of evidence from the Cochrane Collaboration. Nutrition. 2018;45:125-34 e11 Parker EA, Roy T, D'Adamo CR, Wieland LS. Probiotics and gastrointestinal conditions: an overview of evidence from the Cochrane Collaboration. Nutrition. 2018;45:125-34 e11
21.
Zurück zum Zitat Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325-32 Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325-32
Metadaten
Titel
Funktionelle Magen-Darm-Erkrankungen
Therapie-Update Reizdarmsyndrom
verfasst von
Prof. Dr. med. Martin Storr
Publikationsdatum
20.04.2022
Verlag
Springer Medizin
Erschienen in
Gastro-News / Ausgabe 2/2022
Print ISSN: 1869-1005
Elektronische ISSN: 2520-8667
DOI
https://doi.org/10.1007/s15036-022-2471-9